Table 3.
Antibiotic Resistance by Pooled Antibiotic Susceptibility Testing (P-AST) and Antibiotic Resistance (ABR) Gene Presence for All 14 Antibiotics Analyzed
Antibiotics (Total N = 1155) | Sample size | Antibiotic Resistance by P-AST | Detection of Associated ABR Genes |
---|---|---|---|
Amoxicillin/Clavulanate | 1084 | 29.1% | 36.8% |
Ampicillin | 916 | 48.9% | 30.1% |
Ampicillin/Sulbactam | 1067 | 31.8% | 36.6% |
Cefaclor | 1153 | 49.3% | 35.7% |
Cefazolin | 1109 | 38.2% | 35.8% |
Cefepime | 1154 | 40.9% | 35.7% |
Cefoxitin | 1132 | 44.9% | 36.0% |
Ceftazidime | 1155 | 46.3% | 35.7% |
Ceftriaxone | 1110 | 50.9% | 36.5% |
Ciprofloxacin | 1154 | 35.4% | 0.3% |
Levofloxacin | 1153 | 29.7% | 0.3% |
Meropenem | 1155 | 24.1% | 0.3% |
Piperacillin/Tazobactam | 1155 | 6.2% | 35.7% |
Vancomycin | 354 | 44.1% | 0.8% |